Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read moreDetails
Two crucial developments – one in Maharashtra and the other in Gujarat – in quick succession show two opposing sides...
Read moreDetails
The BJP and the Congress seem to believe that they are going to reap rich political dividends through their conflicting...
Read moreDetails
What was considered India’s demographic dividend is beginning to appear less like an opportunity and more like a warning signal....
Read moreDetails
By Aakar Patel Headline from this week: “Pune Police withdraws conversion law provisions from 2 cases after officials find Act...
Read moreDetails